GlassScriptPhysician profile
Alberto E Vadillo
NPI 1083606214
$95,450.32
in general payments reported to CMS, 2019-2025
27 companies · $56.52 in 2025
The $56.52 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $9,851 · 2021: $8,468 · 2022: $32K · 2023: $15K · 2024: $13K · 2025: $56.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $6,235 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,880 · Travel and Lodging: $1,982 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,380.00 |
| Food and Beverage | $6,235.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,880.00 |
| Travel and Lodging | $1,981.53 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $760.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $39,140.02 | 2019-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $35,387.29 | 2019-2024 | Watchman Flx, Avvigo Guidance System, Sentinel |
| Medtronic, INC. | $7,869.45 | 2021-2025 | Onyx Frontier, Ffrangio, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $6,023.83 | 2021-2024 | Diamondback Coronary, Diamondback Peripheral, Ensite Precision |
| Medtronic Vascular, INC. | $2,964.00 | 2019-2020 | |
| Amgen INC. | $1,076.80 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $870.54 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $336.22 | 2019-2024 | Xarelto |
| Pfizer INC. | $313.75 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.67 | 2021-2022 | |
| Shockwave Medical, INC | $297.98 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $168.24 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $146.65 | 2019-2023 | |
| Chiesi USA, INC. | $100.89 | 2022-2024 | Kengreal, Cleviprex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.32 | 2019-2025 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $63.01 | 2023 | Edarbi, Horizant |
| Atricure, INC. | $58.86 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $54.30 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $39.00 | 2022-2023 | Eliquis |
| Edwards Lifesciences Corporation | $34.73 | 2021 | |
| Heartflow, INC. | $24.35 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.00 | 2020 | |
| Gilead Sciences, INC. | $19.30 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.17 | 2020 | |
| Allergan, INC. | $16.01 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.91 | 2019 | |
| Ambu INC. | $7.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Vadillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.